This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Related letters  • Related article  • Similar articles in this journal  Topic Collections  • Nutrition/ Malnutrition  • Statistics and Research Methods  • Diagnosis  • Alert me on articles by topic  Social Bookmarking   What's this?

Ola Landgren, MD, PhD; Gloria Gridley, MS; Neil E. Caporaso, MD; Ingemar Turesson, MD, PhD

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In reply

Weinreb and colleagues correctly point out that many cases of GD type 3 involve seriously ill children with multiple symptoms affecting the hematopoietic, lymphatic, and the neurological organ systems. In our study, we assessed risk of malignant disease among adult (age 18 years) male military veterans admitted to VA hospitals with a GD diagnosis.¹ Individuals with early-onset severe GD are likely not included in this study because they were almost certainly disqualified from military service in younger years.

Weinreb et al also raise 2 questions about the number of individuals with GD and the applied underlying ICD codes in our study. Our answers follow.

We defined a total of 1525 GD patients. As described in the "Methods" section of our article,^1(p1190) the cohort was identified from discharge records for all inpatient hospitalizations at . . . [Full Text of this Article]

AUTHOR INFORMATION


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

RELATED LETTERS

Risk of Malignant Disease Among 1525 Adult Male US Veterans With Gaucher Disease
Ola Landgren, Ingemar Turesson, Gloria Gridley, and Neil E. Caporaso
Arch Intern Med. 2007;167(11):1189-1194.
ABSTRACT | FULL TEXT  

Prevalence of Type 1 Gaucher Disease in the United States
Neal J. Weinreb, Hans C. Andersson, Maryam Banikazemi, John Barranger, Ernest Beutler, Joel Charrow, Gregory A. Grabowski, Carla E. M. Hollak, Paige Kaplan, Henry Mankin, Pramod K. Mistry, Barry E. Rosenbloom, Stephan vom Dahl, and Ari Zimran
Arch Intern Med. 2008;168(3):326-327.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Risk of Non-Hodgkin Lymphoma and Lymphoproliferative Precursor Diseases in US Veterans With Hepatitis C Virus
Thomas P. Giordano, Louise Henderson, Ola Landgren, Elizabeth Y. Chiao, Jennifer R. Kramer, Hashem El-Serag, and Eric A. Engels
JAMA. 2007;297(18):2010-2017.
ABSTRACT | FULL TEXT